Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

MoonLake Immunotherapeutics (MLTX) Times Interest Earned (2022 - 2026)

MoonLake Immunotherapeutics' Times Interest Earned history spans 3 years, with the latest figure at -$30.86 for Q1 2026.

  • Quarterly Times Interest Earned rose 98.83% to -$30.86 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$28.15 through Mar 2026, up 99.7% year-over-year, with the annual reading at -$33.78 for FY2025, N/A changed from the prior year.
  • Times Interest Earned came in at -$30.86 for Q1 2026, up from -$32.71 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$22.34 in Q3 2025 to a low of -$24265.3 in Q1 2022.
  • The 3-year median for Times Interest Earned is -$31.78 (2025), against an average of -$4503.2.
  • The largest YoY upside for Times Interest Earned was 98.83% in 2026 against a maximum downside of 98.83% in 2026.
  • MoonLake Immunotherapeutics' Times Interest Earned stood at -$24265.3 in 2022, then skyrocketed by 99.87% to -$32.71 in 2025, then grew by 5.64% to -$30.86 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Times Interest Earned are -$30.86 (Q1 2026), -$32.71 (Q4 2025), and -$22.34 (Q3 2025).